Articles tagged "Donors, unrelated"

2022 American Transplant Congress
Stabilization of Cell-Cell Junctions Improves Outcomes in an Ex-Vivo Porcine Renal Ischemia-Reperfusion Injury Culture Model
L. Plumblee¹, K. Patel², L. Langerude³, Z. Tu³, D. Nord⁴, T. Beduschi³, S. Nadig⁵, C. Atkinson⁶
¹MUSC College of Medicine, Gainesville, FL, ²University of Virgina, Charlottesville, VA, ³University of Florida, Gaineville, FL, ⁴Division of Pulmonary, Critical Care, and Sleep Medicine, University of Florida, Gainesville, FL, ⁵Northwestern University, Charleston, SC, ⁶Pulmonary Medicine, University of Florida, Gainesville, FL
*Purpose: Renal transplant is an accepted therapy for end-stage renal failure. Chronic transplant dysfunction remains the leading cause of long-term graft loss and is, in…
2022 American Transplant Congress
Domino Living Donor Kidney Transplant Following Therapeutic Nephrectomy for Renal Artery Stenosis with Arterial Reconstruction and Viability Assessment Using Ex Vivo Normothermic Perfusion: A Case Series
R. Pearson¹, J. Wubetu¹, K. Stevenson¹, E. Aitken¹, A. Jackson¹, M. Clancy², D. B. Kingsmore¹
¹Renal Transplant, Queen Elizabeth University Hospital, Glasgow, Glasgow, United Kingdom, ²Renal Transplantation, Queen Elizabeth University Hospital, Glasgow, United Kingdom
*Purpose: Ex vivo normothermic perfusion (EVNP) is increasingly recognized as a viability tool to increase organ utilization. We report use of EVNP to assess graft…
2022 American Transplant Congress
Impact of Donor and Recipient Characteristics on Early Post-Transplant Donor-Derived Cell-Free DNA (dd-cfDNA) Scores
A. Alam¹, J. Zeng², J. Teuteberg³, S. Hall¹
¹Baylor University Medical Center, Dallas, TX, ²CareDx, Brisbane, CA, ³Stanford University, Stanford, CA
*Purpose: Dd-cfDNA (AlloSure, CareDx; Brisbane, CA) has been demonstrated to detect allograft injury after heart transplantation in a large and diverse patient cohort in the…
2021 American Transplant Congress
Associations of Lack of Insurance and Other Sociodemographic Traits with Deficiencies in Follow-Up After Living Kidney Donation
K. Lentine¹, R. Hays², N. Lam³, A. Tietjen⁴, A. Muiru⁵, H. Xiao¹, A. Garg⁶, C. Thomas⁷, G. McNatt⁷, R. Howey⁸, U. Lebron-Banks⁹, M. Cooper¹⁰, M. Conboy¹¹, B. Kasiske¹¹
¹Saint Louis Univ, Saint Louis, MO, ²Univ of Wisconsin, Madison, WI, ³Univ of Calgary, Calgary, AB, Canada, ⁴St. Barnabas, Livingston, NJ, ⁵Univ of California, San Francisco, San Francisco, CA, ⁶Western Univ, London, ON, Canada, ⁷Univ of Iowa, Iowa City, IA, ⁸Toyon Associates, Concord, CA, ⁹New York Presb Hosp, New York, NY, ¹⁰Medstar-Georgetown, Washington, DC, ¹¹SRTR, Minneapolis, MN
*Purpose: Follow-up after living kidney donation in the United States has improved with recent policy mandates. We hypothesized that lack of insurance at donation may…
2021 American Transplant Congress
Donor Lymphocytes in Peripheral Blood of Patients After Lung Transplantation Comprise High Frequencies of Killer Cell Immunoglobulin-like Receptor-positive T and NK Cell Subsets
J. F. Kühne¹, A. Hitz¹, K. A. Bläsing¹, B. Wiegmann², R. Bellmàs Sanz¹, F. Ius², A. Haverich², G. Warnecke², C. S. Falk¹
¹MHH, Institute of Transplant Immunology, Hannover, Germany, ²MHH, Department for Cardiothoracic, Transplantation and Vascular Surgery, Hannover, Germany
*Purpose: For end-stage lung diseases, lung transplantation (LuTx) is the only curative treatment option. However, acute and chronic rejections are major limitations. Thus, a deeper…
2021 American Transplant Congress
General Public Attitude Toward Vascularized Composite Allografts (VCA) Donation?
M. S. S Gharibdousti¹, M. T Khasawneh¹, A. L Friedman²
¹System Science and Industrial Engineering, Binghamton University, Vestal, NY, ²LiveOnNY, New York City, NY
*Purpose: To analyze factors associated with affirmative authorization for VCA donation from public opinion.*Methods: KnowledgePanel is the largest online panel that relies on probability-based sampling…
2021 American Transplant Congress
Current Practices for Management and Treatment of COVID-19 in Immunocompromised Adults: A Survey of Institutions
H. H. Nam¹, S. Aslam², O. Beaird³, G. Forrest⁴, M. Fung⁵, A. Limaye⁶, A. Multani³, J. Nelson⁷, R. Rakita⁶, L. Strasfeld⁸, J. Schaenman³
¹Medicine, University of California - Irvine, Orange, CA, ²Division of Infectious Diseases and Global Public Health, University of California - San Diego, San Diego, CA, ³Medicine, University of California - Los Angeles, Los Angeles, CA, ⁴Medicine, Rush University, Chicago, IL, ⁵Medicine, University of California - San Francisco, San Francisco, CA, ⁶Medicine, University of Washington, Seattle, WA, ⁷Medicine, Stanford University, Palo Alto, CA, ⁸Medicine, Oregon Health and Science University, Portland, OR
*Purpose: The optimal testing strategy for solid organ transplantation (SOT) donor and recipient evaluation, as well as treatment for COVID-19 is unknown. We assessed the…
2021 American Transplant Congress
Clinical Outcomes of Living Kidney Transplantation from Elderly Spousal Donors
Y. Miyauchi, T. Noda, N. Miura, T. Kikugawa, T. Saika
Ehime University, Toon, Japan
*Purpose: In Japan, the spousal kidney transplantation accounts for approximately 40% out of whole living kidney transplantation. In addition, about half of whole living donors…
2021 American Transplant Congress
Robotic Assisted Donor Nephrectomy: A Single Center Experience
A. Khan, A. Sharma, S. Lee, A. Cotterell, D. Kumar, L. Kamal, I. Moinuddin, D. Bruno, V. Kumaran, M. Levy, C. Bhati
Transplant Surgery, Virginia Commonwealth University, Richmond, VA
*Purpose: Robotic donor nephrectomy (RLDN) is an emerging procedure of choice for living kidney donors at many programs. This approach has benefit of minimal invasive…
2021 American Transplant Congress
Machine Learning Informs Utility-Based Non-Directed Living Liver Donor Allocation
K. Bambha¹, J. Perkins¹, M. Sturdevant¹, S. W. Biggins¹, R. Bakthavatsalam¹, P. Healey², A. Dick², J. Reyes¹
¹University of Washington, Seattle, WA, ²Seattle Children's, Seattle, WA
*Purpose: To maximize non-directed living liver donor graft utility, we developed analytic models predicting 10-year graft survival post liver transplant (LT).*Methods: We analyzed OPTN living…